Skip to main content

VANGUARD GROUP INC

Position in BTAI — BioXcel Therapeutics, Inc.

CIK 102909 Valley Forge, PA

Position in BTAI

as of Dec 31, 2025 · filed Jan 29, 2026
Position Value
$468,403
-$23,436 QoQ
Shares Held
292,753
+52.4% QoQ
Ownership
0.948%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 29.00773006596004.ToString("F0")% None 70.99226993403995.ToString("F0")%

Common Shares in BTAI Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Dec 31, 2025

VANGUARD GROUP INC holds $16,658,868,137 across 58 Drug Manufacturers - Specialty & Generic names. BTAI ranks #55 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BTAI

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2025-12-31 $468,403 292,753
2025-09-30 $491,839 192,125
2025-06-30 $34,071 18,824
2025-03-31 $38,211 18,824